Ultrasound Guided Nerve Block for Hip Fracture Pain Management at Emergency Department

NCT ID: NCT05403073

Last Updated: 2022-06-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-30

Study Completion Date

2023-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective is to determine if ultrasound guided suprainguinal iliac fascia block leads in better clinical outcomes such as pain management or time to home discharge.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Determining effectiveness in ultrasound guided suprainguinal iliac fascia block as a tool of comfortability of patients with less use of opioids and their side effects and its possible influence in early discharge to home has no evidence in orthopedics literature till today.

Ultrasound becomes an accessible tool at Emergency Departments and Orthopedic Surgeons are increasingly interested its clinical use.

This clinical trial wants to investigate if its use for hip nerve block leads in better clinical outcomes such as pain management or time to home discharge.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Fractures Pain, Acute Ultrasound Therapy; Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No Nerve Blocking

Pain management at ER Department will be as usually with iv drugs and 3 kilogram soft traction.

Group Type NO_INTERVENTION

No interventions assigned to this group

Ultrasound Nerve blocking

Pain management at ER Department will be as usually with iv drugs and ultrasound guided Suprainguinal Iliac Fascia Nerve Block.

Group Type ACTIVE_COMPARATOR

Ultrasound guided Suprainguinal Iliac Fascia Nerve Block.

Intervention Type PROCEDURE

Pain management at ER Department will be as usually with iv drugs and ultrasound guided Suprainguinal Iliac Fascia Nerve Block.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound guided Suprainguinal Iliac Fascia Nerve Block.

Pain management at ER Department will be as usually with iv drugs and ultrasound guided Suprainguinal Iliac Fascia Nerve Block.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Low energy Hip Fracture

* Present any other synchronic fracture.
* Drug allergy for drugs used for nerve blocking
* Skin infection at injection site.
* Contraindication due to comorbidities.
* Pathologic fractures.
* Cognitive impairment
* Do not give his consent.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital San Carlos, Madrid

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Borja Alcobía-Díaz MD, PhD

MD, PhD, Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Borja Alcobía-Díaz, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Clinical Assistant

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Borja Alcobía-Díaz, MD, PhD

Role: CONTACT

913303001 ext. 3638

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

22/027-EC_X

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.